HSBC Holdings’s Bioverativ Inc. Common Stock BIVV Stock Holding History

HSBC Holdings’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-99,003	Closed	-$5.34M	–	2644
2017 Q4	$5.34M	Buy	99,003 +47,615	+93%	+$2.61M	0.01%	828
2017 Q3	$2.93M	Buy	51,388 +11,938	+30%	+$699K	﹤0.01%	1201
2017 Q2	$2.37M	Sell	39,450 -3,702	-9%	-$211K	﹤0.01%	1222
2017 Q1	$2.32M	Buy	+43,152	New	+$2.13M	﹤0.01%	1182

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

HSBC Holdings's BIVV Position: Q1 2018 in Review

HSBC Holdings sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 99,003 shares — an estimated $5.34M sold.

HSBC Holdings first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $5.34M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

HSBC Holdings reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
HSBC Holdings sold 99,003 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5.34M.
HSBC Holdings first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
HSBC Holdings's Bioverativ Inc. Common Stock position peaked at $5.34M in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on HSBC Holdings's 13F filing for Q1 2018, filed 11 May 2018.